Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$6.69 - $11.99 $229,159 - $410,705
34,254 Added 42.14%
115,545 $986,000
Q1 2023

May 15, 2023

BUY
$8.44 - $13.47 $421,240 - $672,287
49,910 Added 159.05%
81,291 $747,000
Q4 2022

Feb 14, 2023

SELL
$9.71 - $15.86 $534 - $872
-55 Reduced 0.17%
31,381 $320,000
Q3 2022

Nov 14, 2022

SELL
$10.96 - $15.45 $161,462 - $227,609
-14,732 Reduced 31.91%
31,436 $463,000
Q2 2022

Aug 15, 2022

BUY
$7.41 - $11.56 $198,091 - $309,033
26,733 Added 137.55%
46,168 $495,000
Q1 2022

May 16, 2022

BUY
$9.89 - $17.25 $192,212 - $335,253
19,435 New
19,435 $210,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $719M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.